Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin
Da‐Liang Ou(National Taiwan University), Ann‐Lii Cheng(National Taiwan University)
Cited by 46
Related Papers
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|Journal for ImmunoTherapy of Cancer|2021|144
Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression
|Clinical Cancer Research|2015|49